Skip to main content Skip to office menu Skip to footer
Capital IconMinnesota Legislature

2019-2020 Regular Session

Unofficial Status of HF284

Short Description: Insulin products sold in Minnesota cost review authorized by commissioner of health, excessive cost determined, maximum level of reimbursement established for insulin products if necessary, and money appropriated.